Cargando…
1054 Immunogenicity And Safety of Quadrivalent Influenza Vaccine Administered Intradermally (ID) in Adults 18 through 64 Years of Age
Autores principales: | Gorse, Geoffrey J., Falsey, Ann, Landolfi, Victoria, Ozol-Godfrey, Ayca, Tsang, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781631/ http://dx.doi.org/10.1093/ofid/ofu052.762 |
Ejemplares similares
-
1059 Expanded immunogenicity of high-dose inactivated influenza vaccine compared to standard-dose inactivated influenza vaccine in older adults
por: Diazgranados, Carlos, et al.
Publicado: (2014) -
1050 Evaluation of syncope and related events following vaccination with quadrivalent human papillomavirus vaccine (2006-2013)
por: Lievano, Fabio, et al.
Publicado: (2014) -
740 Hospital Avoidance Utilizing an ID Supervised OPAT Program
por: Skorodin, Nathan, et al.
Publicado: (2014) -
1580 Sexual Health of HIV Infected Patients Attending KUMC ID Clinic
por: Muraru, Mihai, et al.
Publicado: (2014) -
1080 Antibody Persistence 5 Years After Vaccination at 2 to 10 Years of Age With Quadrivalent MenACWY-CRM Conjugate Vaccine, And Responses To a Booster Vaccination
por: Block, Stanley L., et al.
Publicado: (2014)